2007, Number 4
<< Back Next >>
Rev Neurol Neurocir Psiquiat 2007; 40 (4)
Time delay for medical care as prognostic factor in stroke
Figueirôa FLS, Marins EG, Brandão JCN, Andrade-Filho AS
Language: Portugués
References: 20
Page: 102-108
PDF size: 57.93 Kb.
Text Extraction
Many therapies had been proposed for acute stroke, few of them had been proved useful for clinical practice. It is possible that the therapeutic window for stroke is narrow, whichever treatment tried.
Objective. This study aims to assess if time delay for medical care is associated to prognosis in acute stroke patients.
Methods. Patients with acute stroke admitted to a private tertiary hospital in Salvador, Bahia, northeastern Brazil were followed up to hospital discharge. Prognosis were measured by the modified Rankin Scale, as good for scores 0-2 and poor for scores 3-6. Time delay for first medical attention was analyzed as a categorical variable, cut points in 3, 6 and 12 hours, and delay for neurologist consultation with cut points in 6 and 12 hours after hospital admission. Median time for first care was compared among good and poor prognosis patients using the Mann-Whitney test.
Results. 88 patients fulfilled the criteria, 61% were female, 74% were over 60 years age, mean time for first care was 6,9h, median time in 3,3h, interquartile from 1 to 9h, mean time for neurologist was 11,2h, median time in 7h, interquartile 2,3 to 18h. Good prognosis frequencies were the same among patients receiving first care before and after 6 hours (40%), similar for patients receiving first care before and after 3 hours (44 x 38%), and for neurologist visiting before and after 6 hours (46 x 43%) and 12 hours (41 x 48%).
REFERENCES
Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1980; 58: 113-30.
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue Plasminogen Activator For Acute Ischemic Stroke. N Engl J Med 1995; 333(24): 1581-7.
Baron JC, von Kummer R, del Zoppo GJ. Treatment of Acute Ischemic Stroke. Challenging the Concept of Rigid and Universal Time Window. Stroke 1995; 26(12): 2219-25.
Sociedade Brasileira de Doenças Cerebrovasculares. Primeiro Consenso Brasileiro do Tratamento da Fase Aguda do Acidente Vascular Cerebral. Arq Neuropsiquiatr 2001; 59(4): 972-80.
Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P. Factors Influencing Early Admission in a French Stroke Unit. Stroke 2002; 33: 153-9.
Cote R, Hachinski VC, Shurvell BL, Norris JW Wolfson C. The Canadian Neurological Scale study in acute stroke. Stroke 1986; 17: 731-7.
Duncan PW, Jorgensen HS, Wade DT. Outcome Measures in Acute Stroke Trials. A Systematic Review and Some Recommendations to Improve Practice. Stroke 2000; 31: 1429-38.
Bonita R, Beaglehole R. Modification of Rankin Scale: Recovery of motor function after stroke. Stroke 1988; 19(12): 1497-500.
Dávalos A, Castillo J, Martinez-Vila E. Delay in Neurological Attention and Stroke Outcome. Stroke 1995; 26(12): 2233-7.
Summer MM, Ozdemir I, Tascilar N. Predictors of Outcome after acute ischemic stroke. Acta Neurol Scand 2003; 107: 276-80.
Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill P, Anderson CS, et al. Five-Year Survival After First-Ever Stroke and Related Prognostic Factors in the Perth Community Stroke Study. Stroke 2000; 31: 2080-6.
Davalos A, Toni D, Iweins F, Lesaffre E, Bastianello S, Castillo J. Neurological Deterioration in Acute Ischemic Stroke. Stroke 1999; 30: 2631-6.
Longstreth Jr WT, Bernick C, Fitzpatrick A, Cushman M, Knepper L, Lima J, Furberg CD. Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology 2001; 56: 368-75.
Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill P, Anderson CS et al. Five-Year Survival After First-Ever Stroke and Related Prognostic Factors in the Perth Community Stroke Study. Stroke 2000; 31: 2080-6.
Goldstein LB, Matchar DB, Hoff-Lindquist J, Samsa GP, Horner RD. VA Stroke Study. Neurologist care is associated with increased testing but improved outcomes. Neurology 2003; 61: 792-6.
Gubitz G, Sandercock P. Acute ischaemic stroke. BMJ 2000; 320: 692-6.
Del Zoppo GJ, Schimid-Schönbein GW, Mori E, Copeland BR, Chang CM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion in the baboons. Stroke 1991; 22: 1276-83.
Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project. J Neurol Neurosurg Psychiatr 1990; 53(10): 824-9.
Planas AM. Alteraciones de la membrane cellular y de la síntesis de proteínas em modelos experimentales de isquemia cerebral: implicaciones farmacológicas para el tratamiento de la patologia isquêmica. Em: Imirizaldu JJZ, Pareja FB, Santiago DC, Abizanda IF, García AG (eds.). Membrana Neuronal y Patologia Cerebral. 1a. Ed. Barcelona: Edipharma; 2000, p. 53-63.
Serena J, Dávalos A, Segura T, Mostacero E, Castillo J. Stroke on Awakening: Looking for a More Rational Manegement. Cerebrovasc Dis 2003; 16(2): 128-33.